All insiders
BL
Burrows Scott L
CFOPrimarily SYRE
0% buying100% selling
Total Trades
26
0 buys · 26 sells
Total Bought
$0
Total Sold
$9.12M
Companies
1
Buy Win Rate
—
insufficient data
Avg Buy Return*
—
Active
Mar 3, 2026 → Oct 1, 2026
Trade Volume by Year
Buy Sell
Top Traded Sectors
Pharmaceutical Preparations26
Most-Traded Stocks
 SYRESpyre Therapeutics, Inc. | 26 | 0B / 26S | $9.12M |
Trade History
| Oct 1, 2026 | SYRE | SELL | 229 | $93.57 | $21.43K |
| Oct 1, 2026 | SYRE | SELL | 3,071 | $92.95 | $285.45K |
| Oct 1, 2026 | SYRE | SELL | 2,100 | $91.92 | $193.03K |
| Oct 1, 2026 | SYRE | SELL | 1,500 | $90.27 | $135.41K |
| Oct 1, 2026 | SYRE | SELL | 600 | $89.07 | $53.44K |
| Sep 30, 2026 | SYRE | SELL | 17,500 | $89.89 | $1.57M |
| Sep 2, 2026 | SYRE | SELL | 18,232 | $89.35 | $1.63M |
| Sep 1, 2026 | SYRE | SELL | 4,384 | $87.11 | $381.89K |
| Sep 1, 2026 | SYRE | SELL | 900 | $86.25 | $77.63K |
| Sep 1, 2026 | SYRE | SELL | 2,016 | $88.03 | $177.47K |
| Sep 1, 2026 | SYRE | SELL | 200 | $89.04 | $17.81K |
| Aug 3, 2026 | SYRE | SELL | 100 | $97.10 | $9.71K |
| Aug 3, 2026 | SYRE | SELL | 5,100 | $95.21 | $485.57K |
| Aug 3, 2026 | SYRE | SELL | 2,300 | $96.30 | $221.49K |
| Jul 1, 2026 | SYRE | SELL | 1,725 | $88.37 | $152.44K |
| Jul 1, 2026 | SYRE | SELL | 5,775 | $87.55 | $505.60K |
| Jun 25, 2026 | SYRE | SELL | 10,000 | $87.14 | $871.40K |
| Jun 25, 2026 | SYRE | SELL | 5,000 | $87.12 | $435.60K |
| Jun 1, 2026 | SYRE | SELL | 2,599 | $70.77 | $183.93K |
| Jun 1, 2026 | SYRE | SELL | 3,100 | $72.06 | $223.39K |
| Jun 1, 2026 | SYRE | SELL | 1,801 | $69.75 | $125.62K |
| May 1, 2026 | SYRE | SELL | 12,500 | $71.37 | $892.13K |
| Apr 1, 2026 | SYRE | SELL | 6,200 | $49.21 | $305.10K |
| Apr 1, 2026 | SYRE | SELL | 1,300 | $49.98 | $64.97K |
| Mar 3, 2026 | SYRE | SELL | 200 | $41.66 | $8.33K |
1–25 of 26
Page 1 of 2
*Return = current share price vs the insider’s purchase price (buys only). Not the insider’s realized return. Informational only — not investment advice.